A pioneering dental medicine project in Japan is making strides toward clinical trials, with the aim of becoming the world's first tooth-regrowing treatment, according to the country's national news site Mainichi. The upcoming trial will be focused on patients affected by anodontia, a genetic condition characterized by the absence of teeth, or partial anodontia, where people are missing some teeth, as described by the National Organization for Rare Disorders (NORD). Clinical trials are scheduled
“There may be challenges involved in controlling the shape, location and number of regrown teeth. Because the research was conducted on animal models, its applicability to humans remains uncertain, as stressed by Dr. Erinne Kennedy from the American Dental Association.”
Waiting for the first reports of unicorn spirals and Paleolithic grade protuberances from the clinical trials.
Caveat emptor, says the ADA:
“There may be challenges involved in controlling the shape, location and number of regrown teeth. Because the research was conducted on animal models, its applicability to humans remains uncertain, as stressed by Dr. Erinne Kennedy from the American Dental Association.”
Waiting for the first reports of unicorn spirals and Paleolithic grade protuberances from the clinical trials.